What Is Lumpy Skin Disease? Check Symptoms And Precautions Amid Outbreak Alert In Maharashtra
Lumpy Skin Disease, though not harmful to humans, has devastated India's dairy industry over the last two years, causing significant economic losses and livestock deaths. With over 2 lakh cattle deaths reported previously and millions affected by reduced milk production, the warning in Buldhana is a call for timely action.
What Is Lumpy Skin Disease (LSD)?
Lumpy Skin Disease is a viral infection caused by the Capripox virus, primarily affecting cattle and buffaloes. It's classified as a transboundary animal disease, meaning it can spread rapidly across borders and regions.
The disease spreads mainly through the bites of infected vectors like mosquitoes, ticks, and flies, and in some cases, through direct contact with infected animals or contaminated feed and water.
Common Symptoms of LSD in Cattle
Farmers and livestock keepers should look out for these warning signs:
1. Hard skin nodules or lumps spread across the body
2. Fever and fatigue
3. Swollen lymph nodes
4. Drastic drop in milk yield
5. Reduced appetite and movement difficulty
6. Discharge from eyes and nose
Infected cattle often show symptoms within 4–14 days of exposure.
How to Prevent Lumpy Skin Disease?
To limit the outbreak and protect healthy cattle:
1. Vaccinate all eligible animals above 3 months with Biolumpivaxin, a once-a-year vaccine.
2. Isolate infected animals immediately and avoid moving them.
3. Control vectors by using insect repellents and maintaining clean sheds.
4. Avoid sharing equipment between infected and healthy animals.
5. Ensure regular vet check-ups and report any suspicious symptoms early.
All About the Biolumpivaxin Vaccine
The Biolumpivaxin vaccine has been successfully trialed by ICAR-NRCE, Hisar, and Biovet across thousands of cattle and buffaloes under field conditions, as reported earlier by IANS. Here are its key features:
1. Safe and effective for cattle of all age groups
2. Can be used for pregnant and lactating animals
3. Offers protection against severe symptoms and fatality
4. Must be administered once annually
Government Response in Buldhana
The Krishi Vigyan Kendra has initiated a public awareness campaign across Buldhana to educate farmers on how to recognise symptoms and adopt proper precautions. Officials emphasise that timely vaccination and isolation are the best defenses.
Why This Matters to Dairy Farmers
A single infected animal can disrupt the productivity of an entire herd. With LSD leading to milk production losses, reproductive failure, and long-term health issues, farmers are urged to treat this warning with seriousness. Prevention is not just about protecting livestock, it's about securing livelihoods, especially in rural and agrarian communities.
Lumpy Skin Disease is a serious threat to cattle health and dairy economics. With a fresh outbreak looming in Maharashtra's Buldhana district, early action can help prevent another nationwide crisis. Farmers must stay alert, report symptoms early, and vaccinate their livestock without delay.
FAQs
1. Is Lumpy Skin Disease dangerous to humans?
No, LSD only affects cattle and buffaloes; it is not transmissible to humans.
2. What causes LSD to spread?
It spreads through mosquito bites, ticks, flies, and direct contact with infected animals.
3. What is the best way to prevent LSD?
Vaccination with Biolumpivaxin and controlling insect vectors are the most effective methods.
4. Can pregnant or lactating cows be vaccinated?
Yes, Biolumpivaxin is safe for all groups including pregnant and lactating animals.
5. What should I do if my cattle show symptoms?
Immediately isolate the affected animal and contact a local veterinarian for guidance and testing.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 days ago
- Time of India
RFK Jr. and other Trump officials embrace psychedelics after FDA setback
Washington: For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should be approved for Americans grappling with depression, trauma and other hard-to-treat conditions. A presidential administration finally seems to agree. "This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure that happens within 12 months," Health Secretary Robert F. Kennedy Jr. recently told members of Congress. His suggested timeline for green-lighting psychedelic therapy surprised even the most bullish supporters of the drugs. And it comes as psychedelics are making inroads in deep red states like Texas, where former Trump cabinet secretary and ex-governor Rick Perry has thrown his full support behind the effort. The administration's embrace of psychedelics has sparked both excitement as well as concern from those in the field, who worry the drugs might be discredited if they appear to be rushed onto the market or are too closely linked with Kennedy, who is known for controversial views on vaccines, antidepressants and fluoride. "I'm quite optimistic," says Rick Doblin, whose organization has pursued the medical use of MDMA (or ecstasy) since the 1980s. "But I'm also worried that the message the public might get is 'Well, RFK likes psychedelics and now it's approved.'" FDA may reconsider MDMA Under President Joe Biden, the FDA rejected MDMA as a treatment for post-traumatic stress disorder, citing flawed data and questionable research. Regulators called for a new study, likely taking several years. It was a major setback for Doblin and other advocates hoping to see the first U.S. approval of a psychedelic for medical use. But the agency appears ready to reconsider. FDA chief Marty Makary, who reports to Kennedy, has called the evaluation of MDMA and other psychedelics "a top priority," announcing a slate of initiatives that could be used to accelerate their approval. One new program promises to expedite drugs that serve "the health interests of Americans," by slashing their review time from six months or more to as little as one month. Makary has also suggested greater flexibility on requirements for certain drugs, potentially waiving rigorous controlled studies that compare patients to a placebo group. That approach, considered essential for high-quality research, has long been a stumbling point for psychedelic studies, in which patients can almost always correctly guess whether they've received the drug or a dummy pill. The U.S. Department of Health and Human Services and FDA also recently hired several new staffers with ties to the psychedelic movement. "These are all very promising signs that the administration is aware of the potential of psychedelics and is trying to make overtures that they're ready to approve them," said Greg Ferenstein, a fellow at the libertarian Reason Foundation, who also consults for psychedelic companies. "We didn't hear anything about that in the Biden administration" A spokesperson for HHS did not respond to a request for comment. As a presidential candidate, Kennedy discussed how his son and several close friends benefited from using psychedelics to deal with grief and other issues. A number of veterans lobbying for psychedelic access have already met with Trump's Secretary of Veterans Affairs, Doug Collins. "What we're seeing so far is positive," Collins told House lawmakers in May. But some experts worry the hope and hype surrounding psychedelics has gotten ahead of the science. Philip Corlett, a psychiatric researcher at Yale University, says bypassing rigorous clinical trials could set back the field and jeopardize patients. "If RFK and the new administration are serious about this work, there are things they could do to shepherd it into reality by meeting the benchmarks of medical science," Corlett said. "I just don't think that's going to happen." Texas goes all-in on ibogaine research As officials in Washington weigh the future of psychedelics, some states are moving ahead with their own projects in hopes of nudging the federal government. Oregon and Colorado have legalized psychedelic therapy. And last month, Texas approved $50 million to study ibogaine, a potent psychedelic made from a shrub that's native to West Africa, as a treatment for opioid addiction, PTSD and other conditions. The research grant - the largest of its kind by any government - passed with support from the state's former GOP governor, Perry, and combat veterans, some who have traveled to clinics in Mexico that offer ibogaine. Ibogaine is on the U.S. government's ultra-restrictive list of illegal, Schedule 1 drugs, which also includes heroin. So advocates in Texas are hoping to build a national movement to ease restrictions on researching its use. "Governmental systems move slowly and inefficiently," said Bryan Hubbard of Americans for Ibogaine, a group formed with Perry. "Sometimes you find yourself constrained in terms of the progress you can make from within." Ibogaine is unique among psychedelics in both its purported benefits and risks. Small studies and anecdotal reports suggest the drug may be able to dramatically ease addiction and trauma. It was sold for medical use in France for several decades starting in the 1930s, but the drug can also cause dangerous irregular heart rhythms, which can be fatal if left untreated. Some veterans who have taken the drug say the risks can be managed and ibogaine's healing properties go far beyond antidepressants, mood stabilizers, counseling and other standard treatments. Marcus Capone struggled with anger, insomnia and mood swings after 13 years as a Navy Seal. In 2017, at the urging of his wife Amber, he agreed to try ibogaine as a last resort. He described his first ibogaine session as "a complete purge of everything." "But afterward I felt the weight just completely off my shoulders," he said. "No more anxiety, no more depression, life made sense all of a sudden." A nonprofit founded by the Capones, Veterans Exploring Treatment Solutions, or VETS, has helped over 1,000 veterans travel abroad to receive ibogaine and other psychedelics. But federal scientists have looked at the drug before - three decades ago, when the National Institute on Drug Abuse funded preliminary studies on using it as an addiction treatment. The research was discontinued after it identified "cardiovascular toxicity." "It would be dead in the water," in terms of winning FDA approval, longtime NIDA director Nora Volkow said. But Volkow said her agency remains interested in psychedelics, including ibogaine, and is funding an American drugmaker that's working to develop a safer, synthetic version of the drug. "I am very intrigued by their pharmacological properties and how they are influencing the brain," Volkow said. "But you also have to be very mindful not to fall into the hype and to be objective and rigorous in evaluating them."
India.com
5 days ago
- India.com
What Is Lumpy Skin Disease? Check Symptoms And Precautions Amid Outbreak Alert In Maharashtra
A health alert has been issued in Buldhana, Maharashtra, as officials warn of a fresh outbreak of Lumpy Skin Disease (LSD), a highly contagious viral disease that targets cattle and buffaloes. The District Information Office, along with Krishi Vigyan Kendra, has urged farmers to take immediate precautions to stop the spread of the disease and protect their livestock. Lumpy Skin Disease, though not harmful to humans, has devastated India's dairy industry over the last two years, causing significant economic losses and livestock deaths. With over 2 lakh cattle deaths reported previously and millions affected by reduced milk production, the warning in Buldhana is a call for timely action. What Is Lumpy Skin Disease (LSD)? Lumpy Skin Disease is a viral infection caused by the Capripox virus, primarily affecting cattle and buffaloes. It's classified as a transboundary animal disease, meaning it can spread rapidly across borders and regions. The disease spreads mainly through the bites of infected vectors like mosquitoes, ticks, and flies, and in some cases, through direct contact with infected animals or contaminated feed and water. Common Symptoms of LSD in Cattle Farmers and livestock keepers should look out for these warning signs: 1. Hard skin nodules or lumps spread across the body 2. Fever and fatigue 3. Swollen lymph nodes 4. Drastic drop in milk yield 5. Reduced appetite and movement difficulty 6. Discharge from eyes and nose Infected cattle often show symptoms within 4–14 days of exposure. How to Prevent Lumpy Skin Disease? To limit the outbreak and protect healthy cattle: 1. Vaccinate all eligible animals above 3 months with Biolumpivaxin, a once-a-year vaccine. 2. Isolate infected animals immediately and avoid moving them. 3. Control vectors by using insect repellents and maintaining clean sheds. 4. Avoid sharing equipment between infected and healthy animals. 5. Ensure regular vet check-ups and report any suspicious symptoms early. All About the Biolumpivaxin Vaccine The Biolumpivaxin vaccine has been successfully trialed by ICAR-NRCE, Hisar, and Biovet across thousands of cattle and buffaloes under field conditions, as reported earlier by IANS. Here are its key features: 1. Safe and effective for cattle of all age groups 2. Can be used for pregnant and lactating animals 3. Offers protection against severe symptoms and fatality 4. Must be administered once annually Government Response in Buldhana The Krishi Vigyan Kendra has initiated a public awareness campaign across Buldhana to educate farmers on how to recognise symptoms and adopt proper precautions. Officials emphasise that timely vaccination and isolation are the best defenses. Why This Matters to Dairy Farmers A single infected animal can disrupt the productivity of an entire herd. With LSD leading to milk production losses, reproductive failure, and long-term health issues, farmers are urged to treat this warning with seriousness. Prevention is not just about protecting livestock, it's about securing livelihoods, especially in rural and agrarian communities. Lumpy Skin Disease is a serious threat to cattle health and dairy economics. With a fresh outbreak looming in Maharashtra's Buldhana district, early action can help prevent another nationwide crisis. Farmers must stay alert, report symptoms early, and vaccinate their livestock without delay. FAQs 1. Is Lumpy Skin Disease dangerous to humans? No, LSD only affects cattle and buffaloes; it is not transmissible to humans. 2. What causes LSD to spread? It spreads through mosquito bites, ticks, flies, and direct contact with infected animals. 3. What is the best way to prevent LSD? Vaccination with Biolumpivaxin and controlling insect vectors are the most effective methods. 4. Can pregnant or lactating cows be vaccinated? Yes, Biolumpivaxin is safe for all groups including pregnant and lactating animals. 5. What should I do if my cattle show symptoms? Immediately isolate the affected animal and contact a local veterinarian for guidance and testing.
Indian Express
6 days ago
- Indian Express
Govt not to allow sale of biostimulants without scientific approval: Shivraj Singh Chouhan
Two days after he asked chief ministers of states to immediately stop forced sale of nano-fertilisers and biostimulants to farmers, Union Agriculture Minister Shivraj Singh Chouhan Tuesday said the government will not allow the sale of biostimulants without scientific nod. He directed the officials of his ministry to put in place 'clear rules and SOPs (standard operating procedures)' for the sale of biostimulants. Chairing a meeting, Chouhan said that farmers raised numerous complaints about the sale of fake fertilisers, seeds, biostimulants, and nano urea during his visits to villages as part of recently concluded 15-day 'Viksit Krishi Sankalp Abhiyan', where he held direct interactions with them. Chouhan questioned why biostimulants, despite repeated renewals and years of sales, were still in the market even after several complaints stated that they were ineffective. 'Now, only those biostimulants that meet all the criteria and are proven beneficial to farmers will be approved. Approvals will now be based solely on scientific validation, and the responsibility for this will rest entirely with the concerned officials,' he said, according to an official statement. Many companies started selling biostimulants without any rules, but the government will not let this happen at any cost, he said, adding that the government will take action against suspicious manufacturers of biostimulants. 'It is necessary to review biostimulants thoroughly to see how much benefit the farmers are getting from it; if not, then permission to sell it cannot be given,' Chouhan said. He also emphasised the need for the Indian Council of Agricultural Research (ICAR) to evaluate biostimulants. Chouhan instructed the officials to put in place clear rules and SOPs, and said that irregularities will no longer be tolerated. Biostimulants are substances or microorganisms (such as beneficial bacteria, fungi, or plant extracts) that, when applied to seeds, plants, or soil, stimulate natural plant processes. The minister pointed out that for several years, around 30,000 biostimulant products were being sold unchecked, and even in the last four years, around 8,000 products remained in circulation. 'After I enforced stricter checks, the number has now come down to around 650,' he said. It is learnt that the meeting was called impromptu and no notice was given to officials. The meeting was attended by the officials of the Ministry of Agriculture and Farmers Welfare and the ICAR. The biostimulants market in India was valued at approximately USD 355–362 million in 2024 and is projected to reach between USD 1.13 billion and USD 1.2 billion by 2032. On July 13, Chouhan had asked the state governments to immediately stop the 'forced tagging' of nano-fertilisers or biostimulants along with conventional fertilisers such as urea and diammonium phosphate (DAP). In a letter to chief ministers, Chouhan highlighted complaints that retailers are not selling subsidised conventional fertilisers such as urea, DAP, etc. to farmers unless they purchase nano-fertilisers or biostimulants.
